Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of...

Published on 5 Nov 2024 on GuruFocus.com · via Yahoo Finance

Pacira BioSciences Inc (NASDAQ:PCRX) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

Read the rest of the article

Start tracking your investments with Statfolio

Other Stocks to Consider Here are some stocks worth considering from the healthcare space, as our...

Zacks · via Yahoo Finance 17 Feb 2025

Halozyme's fourth-quarter earnings are likely to have gained from higher royalty payments and...

Zacks · via Yahoo Finance 13 Feb 2025

Dana Incorporated Price and Consensus Dana Incorporated price-consensus-chart | Dana Incorporated...

Zacks · via Yahoo Finance 11 Feb 2025

The company possesses a Value Score of A. OMV AG PE Ratio (TTM) OMV AG pe-ratio-ttm | OMV AG Quot...

Zacks · via Yahoo Finance 11 Feb 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 17 Jan 2025

NEW ORLEANS, Jan. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information servic...

Cordele Dispatch 16 Jan 2025

Pacira stock gains 11% on better-than-expected preliminary Q4 sales figures. It also shares a...

Zacks · via Yahoo Finance 13 Jan 2025

Pacira BioSciences Inc (NASDAQ:PCRX) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale o...

GuruFocus.com · via Yahoo Finance 20 Jun 2024

Investors in Pacira BioSciences, Inc. (NASDAQ:PCRX) had a good week, as its shares rose 9.3% to c...

Simply Wall St. via Yahoo Finance 10 May 2024